Panbela Therapeutics Inc Price to Cash Flow Ratio (PCF) Ratios, (PBLA) Valuation Ranking and Trends, Fundamental Ratios

PBLA Price to Cash Flow Ratio	(Sep 30 2024)	(Jun 30 2024)	(Mar 31 2024)	(Dec 31 2023)	(Sep 30 2023)
Cash Flow Trailing 12 Months	III. Quarter	II. Quarter	I. Quarter	IV. Quarter	III. Quarter
Price to Cash Flow (TTM) Ratio	current -	-	-	0.71	0.71
Cashflow TTM Y / Y Change	- %	- %	- %	- %	- %
Cashflow Y / Y Change	- %	- %	- %	- %	- %
Stock performance	to date -17.61 %	-26.73 %	-65.87 %	-91.2 %	-57.73 %

Price to Cash Flow ratio Comment

Panbela Therapeutics Inc recorded Cash outflow in trailing twelve months.

What is Price to Cash Flow Ratio?
Valuation in Major Pharmaceutical Preparations Industry

Price to Cash Flow ratio Company Ranking
Within:	No.
Industry	#
Sector	#
S&P 500	#

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com